COMPANY NEWS


Jubilant Pharmova Ltd
BSE Code 530019 ISIN Demat INE700A01033 Book Value (₹) 145.52 NSE Symbol JUBLPHARMA Div & Yield % 0.43 Market Cap ( Cr.) 18,488.36 P/E * 0 EPS * 1.31 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
Jubilant Pharmova announces voluntary prepayment of USD 75 million term loan Back
(14 Jun 2024)

Jubilant Pharma Holdings Inc., USA (JPHI), a wholly owned subsidiary of Jubilant Pharma (JPL) has issued a notice to its lenders to voluntary prepay USD 75 million term loan, equivalent to Rs. 626 crore, by the next interest payment date i.e. 24 June 2024.

JPL is a wholly owned subsidiary of Jubilant Pharmova. As on 31st March 2024, Jubilant Pharmova reported Gross Debt at Rs. 3,414 Cr. and Net Debt at Rs. 2,457 Cr. on a consolidated basis